Alphanate in Immune Tolerance Induction Therapy
Clinical trial NCT03095287 · TERMINATED
Trial details
- NCT number
- NCT03095287
- Sponsor
- Grifols Therapeutics LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-03
- Primary completion
- 2020-09-18
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.